Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Melaleuca (Nantong) Wellness Science And Technology Co. Ltd. currently manages 1 pending office action in the Chemistry & Materials technology area. This action is being processed in 1 distinct art unit, reflecting a concentrated technical focus for the company's current patent activities. The prosecution involves 1 distinct examiner, DIVIESTI, KARLA ISOBEL, who is responsible for the pending work. This concentration in 1 distinct art unit allows for a specialized legal approach tailored to specific technical standards.
DIVIESTI, KARLA ISOBEL is the busiest examiner for this portfolio, with 1 pending office action under her review. Since there is only 1 pending office action in total, this examiner handles the entire current pending workload for the company. The concentration under 1 distinct examiner means that the prosecution strategy can be highly tailored to the specific requirements of this office contact. This focused approach may simplify the examination process by reducing the number of variables the applicant must manage.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DIVIESTI, KARLA ISOBEL | 1 | 3.4% | +20.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023919 | DIETARY SUPPLEMENT COMPOSITIONS COMPRISING GANODERMA AND METHODS FOR MAKING | DIVIESTI, KARLA ISOBEL | 49d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023919 | DIETARY SUPPLEMENT COMPOSITIONS COMPRISING GANODERMA AND METHODS FOR MAKING | DIVIESTI, KARLA ISOBEL | 49d |
| Art Unit | Apps |
|---|---|
| 1792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18023919 | DIETARY SUPPLEMENT COMPOSITIONS COMPRISING GANODERMA AND METHODS FOR MAKING | DIVIESTI, KARLA ISOBEL | 1792 | §103 | Final Rejection | 49d | Pending | Feb 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial